GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (OTCPK:EKDHF) » Definitions » Debt-to-EBITDA

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Debt-to-EBITDA

: 0.46 (As of Dec. 2023)
View and export this data going back to 2014. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

EKF Diagnostics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $4.41 Mil. EKF Diagnostics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.78 Mil. EKF Diagnostics Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was $11.17 Mil. EKF Diagnostics Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for EKF Diagnostics Holdings's Debt-to-EBITDA or its related term are showing as below:

EKDHF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.48   Med: 0.11   Max: 3.56
Current: 0.53

During the past 13 years, the highest Debt-to-EBITDA Ratio of EKF Diagnostics Holdings was 3.56. The lowest was -1.48. And the median was 0.11.

EKDHF's Debt-to-EBITDA is ranked better than
68.75% of 432 companies
in the Medical Devices & Instruments industry
Industry Median: 1.255 vs EKDHF: 0.53

EKF Diagnostics Holdings Debt-to-EBITDA Historical Data

The historical data trend for EKF Diagnostics Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.08 0.10 -0.71 0.53

EKF Diagnostics Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.13 -0.08 0.10 0.46

Competitive Comparison

For the Medical Devices subindustry, EKF Diagnostics Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKF Diagnostics Holdings Debt-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's Debt-to-EBITDA falls into.



EKF Diagnostics Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

EKF Diagnostics Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.406 + 0.782) / 9.719
=0.53

EKF Diagnostics Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.406 + 0.782) / 11.17
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


EKF Diagnostics Holdings  (OTCPK:EKDHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


EKF Diagnostics Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


EKF Diagnostics Holdings (EKF Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Headlines

From GuruFocus